Series B: Building the Machine
By the time you reach Series B, the question has changed entirely. Series A was about proving you could win customers. Series B is about proving you can build a machine — a repeatable, scalable revenue engine that compounds growth quarter after quarter. The investors writing £20M–£50M cheques at this stage are not betting on potential. They are betting on trajectories, and they will scrutinise every metric you produce.
This is where NovaTech finds itself in Lesson 5 of our Startup Mastery series. The company has proven product-market fit, built a credible customer base, and now needs capital to accelerate. But the Series B process introduces complexity that catches many founders off guard — from SaaS efficiency metrics that dictate how much capital you deserve, to term sheet provisions that can reshape your economics for years to come.
Series B is not about growth at all costs. It is about efficient growth — proving that every pound of capital you deploy generates predictable, compounding returns. The metrics that matter shift from leading indicators (pipeline, engagement) to lagging proof (NRR, GRR, contribution margin).
The Metric That Changes Everything: Net Revenue Retention
If there is one number that defines Series B readiness, it is Net Revenue Retention (NRR). Also called Net Dollar Retention in US-centric firms, NRR measures how much revenue you retain and expand from your existing customer cohort over a trailing twelve-month period.
Net Revenue Retention (NRR) is calculated as: (Starting ARR + Expansion − Contraction − Churn) ÷ Starting ARR × 100. An NRR above 100% means your existing customers are spending more over time, even before you acquire a single new customer.
NRR above 100% is the holy grail of SaaS. It means your revenue base grows organically — every customer you have ever won continues to compound your top line. The best enterprise SaaS businesses operate at 120–140% NRR, meaning they could stop all new sales activity and still grow 20–40% annually from their installed base alone.
GRR vs NRR: Understanding the Full Picture
While NRR gets the headlines, sophisticated investors always examine Gross Revenue Retention (GRR) alongside it. GRR strips out expansion revenue and measures pure retention — how much of your starting ARR you kept, accounting only for contraction and churn.
GRR vs NRR Comparison
| Metric | Formula | What It Measures | Top-Quartile Benchmark |
|---|---|---|---|
| GRR | (Starting ARR − Contraction − Churn) ÷ Starting ARR | Product stickiness and customer satisfaction | >90% |
| NRR | (Starting ARR + Expansion − Contraction − Churn) ÷ Starting ARR | Total revenue health including upsell | >120% |
A company with 135% NRR but 75% GRR has a problem — it is masking significant churn with aggressive upselling to remaining customers. That pattern is unsustainable. NovaTech's 92% GRR alongside 135% NRR tells a healthier story: customers stay, and they buy more over time.
NovaTech started the year with 80 enterprise customers generating £8.4M ARR. By year end, 6 customers churned (£540K lost), 8 contracted their usage (£320K reduction), but 42 customers expanded (£3.2M added). GRR = (£8.4M − £540K − £320K) ÷ £8.4M = 89.8%. NRR = (£8.4M + £3.2M − £540K − £320K) ÷ £8.4M = 128%. The executive team focused on the lower-tier customers showing early contraction signals, lifting GRR to 92% the following quarter.
Expansion Revenue: The Engine Within the Engine
Expansion revenue is what separates good SaaS companies from great ones. There are three primary mechanisms, and the most successful businesses employ all three simultaneously.
Seat-Based Expansion
As customers grow their teams, they add more users. NovaTech charges per-seat for its analytics platform, and the average customer added 2.3 seats per quarter as supply chain teams expanded their use of AI-driven insights.
Usage-Based Expansion
Consumption pricing layers on top of seat licences. NovaTech charges for API calls and data processing volume above included thresholds, capturing value as customers deepen their integration.
Module Upsell
New product modules unlock additional revenue. NovaTech launched a predictive procurement module mid-year, and 38% of existing customers adopted it within six months — driving ACV from £18K to £45K for adopting accounts.
The ACV trajectory is particularly important at Series B. Moving from £18K to £45K average contract value signals that NovaTech is successfully moving upmarket — selling to larger enterprises with bigger budgets and longer retention cycles. This is exactly the trajectory Series B investors want to see, because it compounds naturally as your product matures and your sales team gains enterprise selling experience.
SaaS Efficiency: Are You Burning Capital or Building Value?
Series B investors are obsessed with capital efficiency. They have seen too many companies raise large rounds only to burn through cash with diminishing returns. Two metrics dominate these conversations.
SaaS Efficiency Metrics
| Metric | Formula | What It Tells Investors | NovaTech Score |
|---|---|---|---|
| Magic Number | Net New ARR (Qtr) ÷ Sales & Marketing Spend (Prior Qtr) | Sales efficiency — how much ARR each pound of S&M produces | 0.9 |
| Sales Efficiency Ratio | Gross Profit from New ARR ÷ Fully Loaded CAC | Whether new customers are profitable after acquisition costs | 1.4x |
| Burn Multiple | Net Burn ÷ Net New ARR | How much cash you burn for each pound of new ARR | 1.8x |
| Payback Period | CAC ÷ (ARR per Customer × Gross Margin) | Months to recover customer acquisition cost | 14 months |
A magic number above 0.75 signals that you should invest more in sales and marketing — the machine is efficient enough to justify pouring in fuel. Below 0.5, and investors will question whether your go-to-market motion actually works. NovaTech's 0.9 magic number tells Series B investors that capital deployed into sales and marketing generates strong, predictable returns.
The magic number should be evaluated alongside pipeline coverage and quota attainment. NovaTech maintained 3.2x pipeline coverage (£3.20 in qualified pipeline for every £1 of target) and 78% average quota attainment across the sales team. These supporting metrics confirm that the magic number is not a statistical artefact — the sales machine genuinely works.
Contribution Margin and the Path to Profitability
At Series B, investors want to see a credible path to profitability — even if they are funding continued growth. Contribution margin is the metric that bridges the gap between growth-stage losses and future profitability.
Contribution margin is revenue minus all variable costs directly attributable to serving customers (COGS, hosting, customer success, payment processing). It represents the profit available to cover fixed costs (R&D, G&A) and generate operating profit.
NovaTech's contribution margin had reached 62% by the time it approached Series B investors. With 80% gross margins and 18% of revenue going to variable customer success and infrastructure costs, the unit economics were compelling. The question was not whether the business could be profitable — it was when the founders wanted it to be.
NovaTech's Path to Profitability
At 60% year-on-year growth and 62% contribution margins, NovaTech's financial model showed profitability at approximately £35M ARR — roughly 18 months from the Series B close. The board's strategic decision: use Series B capital to accelerate through this threshold, reaching profitability from a position of market strength rather than slowing growth prematurely.
Term Sheet Economics: What the Fine Print Means
The Series B term sheet introduces provisions that can materially affect founder economics at exit. Two provisions demand particular attention: liquidation preferences and anti-dilution protection.
Liquidation Preferences: Who Gets Paid First
A liquidation preference determines the order in which proceeds are distributed when the company is sold or goes public. At Series B, investors typically negotiate for a 1x liquidation preference — meaning they get their invested capital back before anyone else receives a penny.
Non-Participating Preferred
- Investor chooses: take 1x preference OR convert to common and share pro rata
- Investor picks whichever option yields more
- Founder-friendly — limits downside protection to invested capital
- Standard in competitive rounds
Participating Preferred
- Investor takes 1x preference AND shares in remaining proceeds pro rata
- Effectively "double-dips" — gets money back plus upside
- Investor-friendly — significantly dilutes founder payout
- Common in less competitive rounds or distressed situations
NovaTech's Series B term sheet specified a 1x non-participating liquidation preference — the founder-friendly variant. On a £150M pre-money valuation with £30M invested, the Series B investors hold a 16.7% stake. In an exit scenario at £500M, they would compare their 1x preference (£30M) against their pro-rata share (16.7% × £500M = £83.5M) and choose conversion. The preference only activates if the exit value falls below the point where their pro-rata share exceeds their invested capital.
Anti-Dilution: Protecting Against Down Rounds
Anti-dilution provisions protect investors if the company raises a future round at a lower valuation (a "down round"). The broad-based weighted average mechanism — which NovaTech's term sheet included — is the standard, balanced approach.
Full-ratchet anti-dilution is a red flag. Under full-ratchet, even a small down round reprices all of the investor's shares to the new lower price, causing devastating dilution to founders. Broad-based weighted average is the industry standard and adjusts proportionally based on the size and price of the down round. If an investor insists on full-ratchet, treat it as a significant negotiation point.
Term Sheet Summary: NovaTech Series B
| Provision | NovaTech Terms | Market Standard |
|---|---|---|
| Round Size | £30M | £15M–£50M |
| Pre-Money Valuation | £150M | Revenue-dependent |
| Liquidation Preference | 1x Non-Participating | 1x Non-Participating |
| Anti-Dilution | Broad-Based Weighted Average | BBWA |
| Board Seats | 1 new investor seat (total: 5) | 1–2 investor seats |
| Pro-Rata Rights | Yes, for all Series B investors | Standard |
| Information Rights | Quarterly financials + monthly KPIs | Standard |
Pipeline, Quota, and the Revenue Machine
Series B investors want evidence that your revenue is machine-built, not hero-driven. Three pipeline metrics demonstrate this.
Pipeline coverage measures the ratio of qualified pipeline to quota target. NovaTech maintained 3.2x coverage, meaning for every £1 of quarterly target, the team had £3.20 in qualified opportunities. Industry benchmarks suggest 3x minimum for predictable revenue attainment.
Quota attainment distribution matters more than the average. NovaTech's 78% average attainment masked an important detail: 6 of 8 account executives were above 70%, and 3 were above 100%. No single rep drove more than 18% of new ARR. This distribution proves the machine works independent of any individual — precisely what investors need to see before funding headcount expansion.
Sales cycle length and win rates complete the picture. NovaTech's enterprise deals closed in an average of 92 days with a 28% win rate on qualified opportunities. These numbers are consistent enough to be modelled forward with confidence.
The difference between a Series A company and a Series B company is predictability. At Series A, you can say "we think we can sell this." At Series B, you must prove "we know exactly how this machine works, and here is what happens when we put more fuel in." Every metric — NRR, GRR, magic number, pipeline coverage, quota attainment — exists to answer that single question.
NovaTech at Series B: The Full Picture
Twelve months after its Series A, NovaTech approached Series B from a position of strength. The company had grown ARR from £4.2M to £11.8M, expanded its customer base from 45 to 112 enterprise accounts, and proven that its AI-powered supply chain analytics platform generated measurable ROI for customers.
The £30M raise at £150M pre-money valued NovaTech at approximately 12.7x forward ARR — a premium justified by the 135% NRR and the strong efficiency metrics. The capital would fund three priorities: expanding the enterprise sales team from 8 to 20 reps, launching in two new European markets, and investing in the predictive procurement module that was already showing strong early adoption.
Understanding these metrics is not just about raising capital — it is about building an intangible asset base that compounds over time. Customer relationships, proprietary technology, and organisational capital are all strengthened when the revenue machine operates efficiently. For founders navigating the economics of startup growth, our unit economics framework provides the analytical foundation. And for the specific terminology used throughout this lesson, the intangible assets glossary offers precise definitions grounded in accounting standards.
This is Lesson 5 of 8 in the Startup Mastery series: From Idea to Exit. Next lesson: Growth Stage — Operational Excellence.
About the Author
Ivan Gowan is CEO of Opagio, where he leads the development of tools and frameworks that help businesses measure and grow their intangible assets. With over two decades of experience in technology leadership and venture-backed startups, Ivan brings a practitioner's perspective to startup strategy and valuation. Meet the team →
Ivan Gowan is CEO of Opagio, where he builds tools to help companies measure, manage, and grow the intangible assets that drive modern business value.
About the team →Mark Hillier is Chief Commercial Officer at Opagio, specialising in commercial growth strategy, PE exit preparation, and helping founders build investable businesses.
About the team →Lesson 5 Quiz
5 questions to test what you've learned. Your score contributes to your overall Startup Mastery IQ.
Put this knowledge to work
Use Opagio to measure, value, and grow the intangible assets that drive your startup's valuation.